In the wake of the discovery of the novel ALK isoform (ALKATI) identified in melanoma patients, we next characterised ALKRES protein by performing 5′-rapid amplification of cDNA ends (5′-RACE) followed by Sanger sequencing. Here, ALK is linked to melanoma.